Stockreport

IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights [Yahoo! Finance]

IN8bio, Inc.  (INAB) 
PDF Patients (n=10) Treated Remained in Remission, including six Patients Alive and Progression Free Past 12 Months Presented Positive Results from a Phase 1 Study in Newl [Read more]